Skip to main content
SpringerLink
Log in

Mean platelet volume in children with familial Mediterranean fever

  • Brief Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Familial Mediterranean fever (FMF) is the most common inherited periodic fever syndrome characterized by recurrent episodes of serositis. Recently, a few studies have suggested that FMF is related to increased risk of atherosclerosis. Mean platelet volume (MPV) is a marker of platelet activation. Larger platelets are associated with increased atherosclerosis risk. The aim of the study is to evaluate levels of MPV in pediatric FMF patients during and between attacks. The study consisted of 48 patients during an attack (group 1), 63 patients in attack-free period (at least 2 weeks after an attack, group 2), and 49 healthy controls (group 3). Erythrocyte sedimentation rate, C-reactive protein, white blood cell count, platelet count (PLT), and MPV levels were retrospectively recorded from the computerized patient database. Mean platelet volume was significantly lower in FMF patients during attack than in attack-free period (p = 0.00); however, there was no difference among attack-free patients and healthy controls (p = 0.38). The mean platelet counts of FMF patients during attack were higher than the healthy controls (p = 0.02). There was an inverse correlation between MPV and mean PLT in the attack-free period (r = −446, p = 0.01). This study suggests that an early atherosclerosis marker, MPV, is not elevated in pediatric FMF patients on colchicine treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cassidy JT, Petty RE (2005) Periodic fever syndromes in children. In: Cassidy JT, Petty RE (eds) Textbook of pediatric rheumatology, 5th edn. Elsevier, Philadelphia, pp 657–690

    Google Scholar 

  2. Zemer D, Revach M, Pras M et al (1974) A controlled trial of colchicine in preventing attacks of familial Mediterranean fever. New Eng J Med 291:932–934

    Article  PubMed  CAS  Google Scholar 

  3. Zemer D, Pras M, Sohar E et al (1974) Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. New Eng J Med 314:1001–1005

    Google Scholar 

  4. Bagci S, Toy B, Tuzun A et al (2004) Continuity of cytokine activation in patients with familial Mediterranean fever. Clin Rheumatol 23:333–337

    Article  PubMed  Google Scholar 

  5. Colglazier CL, Sutej PG (2005) Laboratory testing in the rheumatic diseases: a practical review. South Med J 98:185–191

    Article  PubMed  Google Scholar 

  6. Caliskan M, Gullu H, Yilmaz S et al (2007) Impaired coronary microvascular function in familial Mediterranean fever. Atherosclerosis 195:161–167

    Article  CAS  Google Scholar 

  7. Akdoğan M, Calguneri M, Yavuz B et al (2006) Are familial Mediterranean fever (FMF) patients at risk for atherosclerosis? Impaired endothelial function and increased intima media thickness. J Am Coll Cardiol 48:2351–2353

    Article  PubMed  Google Scholar 

  8. Peru H, Altun B, Doğan M et al (2008) The evaluation of carotid intima-media thickness in children with familial Mediterranean fever. Clin Rheumatol 27:689–694

    Article  PubMed  Google Scholar 

  9. Bilginer Y, Ozaltin F, Basaran C et al (2008) Evaluation of intima media thickness of the common and internal carotid arteries with inflammatory markers in familial Mediterranean fever as possible predictors for atherosclerosis. Rheumatol Int 28:1211–1216

    Article  PubMed  CAS  Google Scholar 

  10. Ross R (1986) The pathogenesis of atherosclerosis—an update. New Eng J Med 314:488–500

    PubMed  CAS  Google Scholar 

  11. Sarı I, Karaoglu O, Can G et al (2007) Early ultrasonographic markers of atherosclerosis in patients with familial Mediterranean fever. Clin Rheumatol 26:1467–1473

    Article  PubMed  Google Scholar 

  12. Martin JF, Trowbridge EA, Salmon G et al (1983) The biological significance of platelet volume: its relationship to bleeding time, thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res 32:443–460

    Article  PubMed  CAS  Google Scholar 

  13. Thompson CB, Eaton KA, Princiotta SM et al (1982) Size dependent platelet subpopulations: relationship of platelet volume to ultrastructure, enzymatic activity, and function. Br J Haematol 50:509–519

    Article  PubMed  CAS  Google Scholar 

  14. Çoban E, Adanir H (2008) Platelet activation in patients with familial Mediterranean fever. Platelets 19:405–408

    Article  PubMed  CAS  Google Scholar 

  15. Livneh A, Langevitz P, Zemer D et al (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885

    Article  PubMed  CAS  Google Scholar 

  16. Pras E, Livneh A, Balow JE Jr et al (1998) Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet 75:216–219

    Article  PubMed  CAS  Google Scholar 

  17. Seyahi E, Ugurlu S, Cumali R et al (2005) Subclinical atherosclerosis in familial Mediterranean fever. In: Proceedings of the 4th international congress on systemic auto-inflammatory diseases. FMF and Beyond, NIAMS, Bethesda, 6–10 November 2005

  18. Kaser A, Brandacher G, Steurer W et al (2001) Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood 98:2720–2725

    Article  PubMed  CAS  Google Scholar 

  19. van Gameren MM, Willemse PH, Mulder NH et al (1994) Effects of recombinant human interleukin-6 in cancer patients: a phase I–II study. Blood 84:1434–1441

    PubMed  Google Scholar 

  20. Clarke D, Johnson PW, Banks RE et al (1996) Effects of interleukin 6 administration on platelets and haemopoietic progenitor cells in peripheral blood. Cytokine 8:717–723

    Article  PubMed  CAS  Google Scholar 

  21. Baykal Y, Saglam K, Yilmaz MI et al (2003) Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients. Clin Rheumatol 22:99–101

    Article  PubMed  CAS  Google Scholar 

  22. Gang N, Drenth JP, Langevitz P et al (1999) Activation of the cytokine network in familial Mediterranean fever. Rheumatol 26:890–897

    CAS  Google Scholar 

Download references

Disclosures

None.

Author information

Authors and Affiliations

  1. Department of Pediatrics, Division of Pediatric Immunology and Rheumatology, Dokuz Eylül University Hospital, 35340, Balçova, Izmir, Turkey

    Balahan Makay, Zeynep Türkyilmaz & Erbil Ünsal

Authors
  1. Balahan Makay
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zeynep Türkyilmaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Erbil Ünsal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Balahan Makay.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Makay, B., Türkyilmaz, Z. & Ünsal, E. Mean platelet volume in children with familial Mediterranean fever. Clin Rheumatol 28, 975–978 (2009). https://doi.org/10.1007/s10067-009-1148-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-009-1148-5

Keywords

Search

Navigation